Today we’re speaking with Faisal Zain, a leading expert in healthcare policy and economics. A recent SHADAC report has sent ripples through the industry, revealing that employer-sponsored health insurance costs are surging faster than inflation, placing an immense burden on American families and b
The recent strategic acquisition of e-learning specialist Erevo by healthcare technology leader Equasens sends a clear signal that the world of professional medical education is on the brink of a significant transformation. This move, finalized in early 2026, is more than a simple corporate merger;
A Counter-Intuitive Catalyst: Why Lower Prices Led to a Higher Valuation In a move that defied conventional market logic, shares of Ironwood Pharmaceuticals skyrocketed 26.7% on Friday after the company announced a strategic cut to the list price of its flagship drug, Linzess. This decision,
With the healthcare industry buzzing about AI-driven solutions, a quieter, more pragmatic evolution is taking place. While big-box retailers have stumbled in their attempts to conquer primary care, a new wave of hybrid companies is finding success by blending virtual services with targeted,
The price of a single year of life has become a central and contentious calculation in modern medicine, a debate perfectly encapsulated by the arrival of targeted cancer therapies. As scientific breakthroughs deliver treatments with unprecedented efficacy, healthcare systems worldwide grapple with
A Quiet Policy Shift with Seismic Consequences for Primary Care A seemingly minor regulatory change has taken effect, allowing Americans to use their tax-advantaged Health Savings Account (HSA) funds to pay for Direct Primary Care (DPC) memberships. For advocates of patient choice and
